Full history for every metric is available with a Kvantra account
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Operating profit | $m | -7.42 | 3.32 | |||||
| Net profit | $m | -18.5 | -18.0 | -21.8 | -16.9 | -8.5 | -11.2 | -3.3 |
| EPS reported | $ | -20.40 | -0.00 | |||||
| Operating cashflow per share | $ | -0.00 | -0.00 | |||||
| Capex per share | $ | 0.00 | 0.00 | |||||
| FCF per share | $ | -0.00 | -0.00 | |||||
| Free cash flow | $m | -6.86 | -3.34 | |||||
| Net debt | $m | -3.10 | -1.06 | |||||
| Book value equity | $m | 4.40 | 2.27 | |||||
| Book value per share | $ | 11.82 | 0.00 | |||||
| Number of shares | m | 0.37 | 6,780.17 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.54 | 0.53 | |||||
| P/S LTM | x | 0.00 | 0.00 | |||||
| P/FCF LTM | x | -0.35 | -0.36 | |||||
| EV/EBITDA LTM | x | 0.14 | -0.05 | |||||
| EV/Sales LTM | x | 0.00 | 0.00 | |||||
| Earnings Yield LTM | % | -472.32% | -52.79% | |||||
| FCF Yield | % | -288.00% | -275.91% | |||||
| Quality | ||||||||
| ROE | % | -255.67% | -156.40% | |||||
| ROIC | % | -159.20% | 214.02% | |||||
| Operating margin | % | 0.00% | 0.00% | |||||
| Gross margin | % | 0.00% | 0.00% | |||||
| FCF/Sales | % | - | - | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -100.00% | -100.00% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | - | -37.98 | |||||
| Net Debt/EBITDA | x | 0.52 | 0.20 | |||||
| EBIT/Net interest | x | -48.30 | 52.30 | |||||
| Net debt/market cap | % | -130.23% | -87.18% | |||||
| Net debt/Equity | x | -0.70 | -0.47 | |||||
| Gross debt/equity | x | 0.00 | 0.04 | |||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Steakholder Foods Ltd., an advanced deep-tech food enterprise, focuses on developing innovative cultivated meat solutions. Its primary goal is to produce cultured meat products without the need for animal slaughter. The company has engineered a sophisticated three-dimensional bioprinter specifically designed to meticulously layer differentiated stem cells, structural scaffolding, and vital cell nutrients, thereby creating structured cultured meat. Moving forward, Steakholder Foods intends to license its proprietary production technology. Additionally, it plans to supply related products, including cell lines, specialized printheads, bioreactors, and incubators. The firm will also offer various services, such as technology setup, user training, and ongoing technical support, to food processors and retailers, both directly and through strategic partnerships. The company's operations are based in Rehovot, Israel.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Steakholder Foods Ltd. (MTTCF)
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Steakholder Foods Ltd., an advanced deep-tech food enterprise, focuses on developing innovative cultivated meat solutions. Its primary goal is to produce cultured meat products without the need for animal slaughter. The company has engineered a sophisticated three-dimensional bioprinter specifically designed to meticulously layer differentiated stem cells, structural scaffolding, and vital cell nutrients, thereby creating structured cultured meat. Moving forward, Steakholder Foods intends to license its proprietary production technology. Additionally, it plans to supply related products, including cell lines, specialized printheads, bioreactors, and incubators. The firm will also offer various services, such as technology setup, user training, and ongoing technical support, to food processors and retailers, both directly and through strategic partnerships. The company's operations are based in Rehovot, Israel.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free